• Ehsani, D., Salimi, M. Liquid Biopsy for Identifying hsa_Circ_0065173 and hsa_Circ_0008717 as Possible Biomarkers in Breast Cancer Patients Pre- and Post-Chemotherapy. IRCMJ, 2025; 27(1): -. doi: 10.22034/ircmj.2025.440232.0
• Mahdi Alizadeh; Mahdieh Salimi; Zahra Soheila Soheili, Prognostic Significance of E2F8, LIN28b, MACC1, and CCT3 in Breast Cancer: Implications for Survival and Therapeutic Stratification, Articles in Press, Accepted Manuscript, Available Online from 18 May 2025, https://doi.org/10.30498/ijb.2025.497569.4051
• Molla Hoseyni BH, Lanjanian H, Beigi YZ, Salimi M, Zare-Mirakabad F, Masoudi-Nejad A. Molecular landscape of endometrioid Cancer: Integrating multiomics and deep learning for personalized survival prediction. Comput Biol Med. 2025 Jun;192(Pt A):110284. doi: 10.1016/j.compbiomed.2025.110284. Epub 2025 May 3. PMID: 40319755.
• Mahnaz Shavandi, Fatemeh Abutalebian, Mahdieh Salimi, Seyedeh Sara Shafiei,A Brief Review on Layered Double Hydroxides (LDH): Innovative Non-Viral Carriers for Nucleic Acid Delivery,2025,  Volume10, Issue16,  https://doi.org/10.1002/slct.202500766
• Alizadeh M and Salimi M ,Exploring the Role of hsa_circ_0052112 as a Potential Biomarker in Breast CancerInsights from Experimental and In Silico Analyses, Avicenna Journal of Medical Biotechnology, Vol. 17, No. 2, April-June 2025, Issue 2, 136-146, https://doi.org/10.18502/ajmb.v17i2.18565

• S.Behrouzi, M. Salimi, N. Allah yari, Integrated Bioinformatics Analysis Reveals Dysregulation of MiR-548F-3p and Its Associated Hub Gene in Triple-Negative Breast Cancer, Iranian Journal of Basic Medical Sciences, accepted

• Salimi M, Dashti Gohari S. Assessment of Non-Coding RNAs (miR-506 and circRNA 000284) and their Target Gene SNAIL-2 in Breast Tumors: Implications for Prognosis and a Possible Circulating Biomarker. Basic Clin Cancer Res. 2024;15(2):81-93.

• Mirzaei S, Salimi M, Mozdarani H. CircRNAs as Possible Potential Biomarkers for Breast Cancer Prognosis and Chemotherapy Response: A Comprehensive Study. Basic Clin Cancer Res. 2024;15(4):225-236.

• Beigi YZ, Lanjanian H, Fayazi R, Salimi M, Hoseyni BHM, Noroozizadeh MH, Masoudi-Nejad A. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy. Mol Biomed. 2024 May 10;5(1):17. doi: 10.1186/s43556-024-00182-2. PMID: 38724687; PMCID: PMC11082128.

• A KavianFar, H Taherkhani, Ali Ahmadi,  M Salimi, H Lanjanian and A Masoudi‑Nejad, Restoring the epigenetic landscape of lung microbiome: potential therapeutic approach for chronic respiratory diseases, BMC Pulmonary Medicine (2024) 24:2 https://doi.org/10.1186/s12890-023-02789-7
• Nasirpour MH, Salimi M, Majidi F, Minuchehr Z, Mozdarani H. Study of DACH1 Expression and its Epigenetic Regulators as Possible Breast Cancer-Related Biomarkers. Avicenna J Med Biotechnol. 2023 Apr-Jun;15(2):108-117. PMID: 37034893; PMCID: PMC10073918.
• Alizadeh M, Salimi M. Exploring the Role of hsa_circ_0052112 as a Potential Biomarker in Breast Cancer: Insights from Experimental and In Silico Analyses. Avicenna J Med Biotechnol. 2025 Apr-Jun;17(2):136-146. doi: 10.18502/ajmb.v17i2.18565. PMID: 40453910; PMCID: PMC12123178.
• Shavandi M, Abutalebian F,  Salimi M, Shafiei S. A Brief Review on Layered Double Hydroxides (LDH): Innovative Non‐Viral Carriers for Nucleic Acid Delivery, ChemistrySelect, 2025, doi.org/10.1002/slct.202500766
• Molla Hoseyni BH, Lanjanian H, Beigi YZ, Salimi M, Zare-Mirakabad F, Masoudi-Nejad A. Molecular landscape of endometrioid Cancer: Integrating multiomics and deep learning for personalized survival prediction. Comput Biol Med. 2025 Jun;192(Pt A):110284. doi: 10.1016/j.compbiomed.2025.110284. Epub 2025 May 3. PMID: 40319755.
• Farsani AM, Rahimi F, Taebnia N, Salimi M, Arpanaei A. Tailored design and preparation of magnetic nanocomposite particles for the isolation of exosomes. Nanotechnology. 2023 Jan 30;34(15). doi: 10.1088/1361-6528/acb2d2. PMID: 36638529.
•  Taherkhani H, Kavianfar A,  Lanjanian H,  Hosseinkhan N, Salimi M,   Nematzadeh S, Naghizadeh MM, Azimzadeh S,  Masoudi-Nejad A, Interplay of Lung Microbiome and Epigenetics in Former Smokers: A Machine Learning and Fuzzy Logic Approach on COPD Progression, HELIYON, https://doi.org/10.1016/j.heliyon.2025.e42944

• Taherkhani, H. ., Kavianfar, A., & Salimi, M. . (2023). Exploring the Microbial Changes in Meibomian Gland Dysfunction through 16S rDNA Sequencing: Eye Microbiome. Journal of Ophthalmic and Optometric Sciences, 6(1). https://doi.org/10.22037/joos.v6i1.40731

• Salimy S, Lanjanian H, Abbasi K, Salimi M, Najafi A, Tapak L, Masoudi-Nejad A. A deep learning-based framework for predicting survival-associated groups in colon cancer by integrating multi-omics and clinical data. Heliyon. 2023 Jul 5;9(7):e17653. doi: 10.1016/j.heliyon.2023.e17653. PMID: 37455955; PMCID: PMC10344710.
• F Pakniyat; H Mozdarani*; H A Nedaee*; A Mahmoudzadeh; M Salimi; S Gholami. "Bystander Response Following High-Dose X-irradiation; Time-dependent Nature of GammaH2AX Foci and Cell Death Consequences". Journal of Biomedical Physics and Engineering, , , 2020, -. 99-400

• 1-Mohammadi K, Salimi M*, Angaji SA, Saniotis A, Mahjoobi F. Association study of Bif-1 gene expression with histopathological characteristics and hormone receptors in breast cancer. BMC Womens Health. 2022 Nov 24;22(1):471. doi: 10.1186/s12905-022-02075-4. PMID: 36434659; PMCID: PMC9701003. 400-401
• 2-Andia Seyedi Moghaddam , Mahdieh Salimi * , Najmeh Ranji , Hossein Mozdarani , Examining the miR-93-5p and miR-17-5p Expression in Plasma and Breast Cancer Tissue as Possible Markers in Breast Cancer Prognosis, Volume 25, Issue 1 (April & May- 2022)                   J Arak Uni Med Sci 2022, 25(1): 104-119 400-401

• 3-Motahareh Sheikh-Hosseini, Mahdieh Salimi*, Hossein Mozdarani, A-Kinase anchor protein 4 (AKAP4) may be considered as a potential early diagnostic breast cancer marker detectable in blood, Gene Reports, Volume 29,2022,101663,ISSN 2452-0144,https://doi.org/10.1016/j.genrep.2022.101663.(https://www.sciencedirect.com/science/article/pii/S2452014422001716) 400-401

• 4-Sedaghati Burkhani S, Salimi M*. miR-888 and E-Cadherin Levels in Ductal Carcinoma Breast Cancer as Possible Cancer-Related Markers. Genet Test Mol Biomarkers. 2022 Apr;26(4):184-190. doi: 10.1089/gtmb.2021.0194. Epub 2022 Apr 18. PMID: 35442769. 400-401

• 5-SS Moravveji, S Khoshbakht, M Mokhtari, M Salimi, H Lanjanian, Impact of 5HydroxyMethylCytosine (5hmC) on reverse/direct association of cell-cycle, apoptosis, and extracellular matrix pathways in gastrointestinal cancersBMC Genomic Data 23 (1), 1-9 400-401

• 6-SS Moravveji, S Khoshbakht, M Mokhtari, M Salimi, A Masoudi-Nejad, Pan-cancer analysis of biological events on cell cycle instability in gastrointestinal cancers with integrative scoring method, Genomics 114 (1), 253-265 400-401

• 7-Amirhossein Fathinavid, Zaynab Mousavian, Ali Najafi, Sajjad Nematzadeh, Mahdieh Salimi, Ali Masoudi-Nejad, Identifying common signatures and potential therapeutic biomarkers in COPD and lung cancer using miRNA-mRNA co-expression networks, Informatics in Medicine Unlocked,Volume 34,2022,101115,ISSN 2352-9148,https://doi.org/10.1016/j.imu.2022.101115.(https://www.sciencedirect.com/science/article/pii/S2352914822002520) 400-401
• Heidarizadi A, Salimi M, Mozdarani H. Study of DOK4 gene expression and promoter methylation in sporadic breast cancer. Neoplasma. 2020 Jul;67(4):916-921. doi: 10.4149/neo_2020_190811N747. Epub 2020 May 6. PMID: 32386480.   98-99

• Heidarizadi  A, Salimi M, Mozdarani H. 2020. Study of ELF5 expression and promoter methylation status in Breast Cancer Patients, Ilam University of medical sciences, accepted, under press.    98-99
• Andia Seyedi Moghaddam 1, Mahdieh Salimi*2, Najmeh Ranji1, Hossein Mozdarani, Upregulation of miR-21 and miR-106b in plasma and tissues as a possible prognostic marker in aggressive breast cancer, 2021,  Iranian Red Crescent Medical Journal, accepted, under press. 99-400

• Maryam Bakherad, Mahdieh Salimi* , Seyed Abdolhamid Angaji, Frouzandeh Mahjoubi

and Tayebeh Majidizadeh, LRIG1 expression and colorectal cancer prognosis, BMC Med Genomics (2021) 14:20 https://doi.org/10.1186/s12920-020-00846-2 99-400

• F. Pakniyat, S. Gholami, Ph.d., H.a. Nedaie, Ph.d., H. Mozdarani, A. Mahmoudzadeh, M. Salimi, Demonstration of Bystander Response in High Dose Technique of Grid Using Theoretical Calculation By Linear Quadratic Model Along With Experimental Investigations , IJRR, Volume 18, Issue 3 (7-2020)    98-99
• Farzaneh Rahvar ¹, Mahdieh Salimi ¹*, Hossein Mozdarani ²  Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer, Genetics and Molecular Biology, 2020, accepted. Under press.

· Narjes Bakhtari, Hossein Mozdarani, Mahdieh Salimi, Ramesh Omranipour, Association study of miR-22 and miR-335 expression levels and G2 assay related inherent radiosensitivity in peripheral blood of ductal carcinoma breast cancer patients, neo_2020_200225N185

· Fatemeh Pakniyat Hassan Ali Nedaie Hossein Mozdarani Aziz Mahmoudzadeh Mahdieh Salimi, Enhanced Response of Radioresistant Carcinoma Cell Line to Heterogeneous Dose Distribution of Grid; The Role of High-Dose Bystander Effect. Int J Radiat Biol 2020 Oct 19:1-45. Epub 2020 Oct 19.

• Heidarizadi A, Salimi M, Mozdarani H. Study of DOK4 gene expression and promoter methylation in sporadic breast cancer. Neoplasma. 2020 Jul;67(4):916-921. doi: 10.4149/neo_2020_190811N747. Epub 2020 May 6. PMID: 32386480.

• Heidarizadi  A, Salimi M, Mozdarani H. 2020. Study of ELF5 expression and promoter methylation status in Breast Cancer Patients, Ilam University of medical sciences, accepted, under press.

• Salimi M, Afzali F, Unearthing Regulatory Axes of Breast Cancer circRNAs Networks to Find Novel Targets and Fathom Pivotal Mechanisms, Interdisciplinary Sciences 2019 Dec;11(4):711-722. doi: 10.1007/s12539-019-00339-6.

·  Zangeneh M; Nedaei H A,   Mozdarani H;  Mahmoudzadeh A; Kharrazi Sh; Salimi M, Enhanced cytotoxic and genotoxic effects of gadolinium-doped ZnO nanoparticles on irradiated lung cancer cells at megavoltage radiation energies, Materials Science and Engineering Volume 103, October 2019, 109739

•  Zangeneh M; Nedaei H A,   Mozdarani H;  Mahmoudzadeh A; Kharrazi Sh; Salimi M, The role and mechanisms of zinc oxide nanoparticles in the improvement of the radiosensitivity of lung cancer cells in clinically relevant megavoltage radiation energies in-vitro, Nanomedicine journal, DOI: 10.22038/nmj.2019.13128, Articles in Press, Corrected Proof , Available Online from 19 May 2019.
• Salimi M, Rastegarpouyani Sh ,E74-like Factor 5 Promoter Methylation in Circulating Tumor DNA as a New Possible Prognostic Marker in Breast Cancer Patients, APJCP, 2019, accepted.
• Seyedi moghadam A., Salimi M, Mozdarani H., Ranji M., Expression profile study of the panel of miRNAs (miR-21-5p, miR-221/222, miR-17-5p, miR-106b, miR-93-5p) in tumors and trace it in peripheral blood as possible breast cancer related biomarkers, Genes, 2018, under revision.
• Rahvar F, Salimi M*, Mozdarani H, Higher frequency of Guanylate binding protein 2 promoter methylation in plasma DNA of breast cancer patients, APJCO, 2018, under revision.
• Sheikhhosseini M, Salimi M, Mozdarani H , A-Kinase Anchor Protein 4 (AKAP4), a cancer testis antigen, may consider as potential early diagnostic breast cancer markerdetectable in blood, Pathology Oncology Research, 2018, under revision.
• Salimi M, Sedaghati S.,  Study of miR888  expression levels in breast cancer tumors and trace it in plasma as a circulating early detection biomarker, cancer investigation, 2018, under revision.
• Salimi M, Sedaghati S., Integrity and quantity evaluation of plasma cell-free DNA in triple negative breast cancer, AJMB, 2018, accepted, under press.

• Salimi M, Sarrafzadeh Zargar S. Insulin Receptor Substrate 2 mRNA Expression in Urinary Sediment Cells as a Diagnostic Marker of Nephropathy in Diabetic Patients. Iran J Kidney Dis. 2018 May; 12(3):142-149.

•  Salimi M,   Eskandari E, Association of elevated peripheral blood micronucleus frequency and Bmi-1 mRNA expression with metastasis in Iranian breast cancer patient, Asian pacific journal of cancer prevention, 2018 , 19 (10), 2723-2730.

• Salimi M, 2018 Comparative study of chemo-sensitivity expressed as micronuclei in lymphocytes of breast cancer patients, their unaffected first degree relatives and normal controls as a possible prognostic marker, IJRR, 16(1), 85-93.

• Eskandari  E., Salimi M., Mahjoubi F., Up-regulation of Bax-interacting factor-1 in Iranian Colorectal Cancer Patients, Basic and Clinical Cancer Reseearch,   Vol 10 No 2 (2018)

·  Zonozi F, Mozdarani H^, ,  Salimi M,  Mozdarani S ,  Fallahi P,  Mozdarani S,  Heidari Z  High frequency of microdeletion in TTY2 gene family in peripheral blood leukocytes of non-obstructive azoospermia patients, AIMS Genetics, 2017, 4(4): 202-212. doi: 10.3934/genet.2017.4.202.

· Mozdarani H ,  Salimi  M.,  Bakhtari N. Inherent radiosensitivity and its impact on breast cancer chemo-radiotherapy  Int J Radiat Res 2017, 15(4): 325-341.

• Salimi M, 2018 Comparison of a radiomimetic agent sensitivity in breast cancer patients, their unaffected first degree relatives and normal control as a representor of genomic instability and possible prognostic factor, IJRR, under publish.

• Salimi M, Broumand B, Mozdarani H. 2016 Association of elevated frequency of micronuclei in peripheral blood lymphocytes of type 2 diabetes patients with nephropathy complications.Mutagenesis. pii: gew029.

• Khazaie N, Massumi M, Wee P, Salimi M, Mohammadnia A, Yaqubi M. 2016, Involvement of Polycomb Repressive Complex 2 in Maturation of Induced Pluripotent Stem Cells during Reprogramming of Mouse and Human Fibroblasts. PLoS One. Mar 3;11(3):e0150518.

• Mohammadi K, Salimi M, Angaji AH, Mahjoubi F, Majidizadeh T. 2016. BIf-1 relative gene expression study in breast cancer tumor and normal adjacent tissues using Real-Time PCR, Ilam University of medical sciences, accepted, under press.

• Shirani Sh., Mozdarani H., Mahmoodzadeh A., Salimi M. (2015) Radio-adaptive response of peripheral blood lymphocytes following bystander effects induced by preirradiated CHO-K1 cells using the micronucleus assay, Int. J. R. R., April 2015, 13(2):151-156.

• Salimi M. Mozdarani H. (2015) Different aspects of CBMN assay as a comprehensive measurement tool for chromosomal instability focus on radiobiodosimetery. A review article, IJRR. 2015, 13(2):101-126.

• Salimi M., Mozdarani H., Nazari  E. (2014)Cytogenetic alterations in preimplantation mice embryos following paternal gamma-irradiation expressed as numerical chromosomal abnormalities and micronuclei: Comparison of two methods for reproductive toxicity screening ,Avicenna journal of Medical Biotechnology;6(3):130-9.

• Salimi M., Mozdarani H. (2014) γ-H2AX as a protein biomarker for radiation exposure response in ductal carcinoma breast tumors: Experimental evidence and literature Review. IJRR., 12(1):1-11.

• Salimi M., Mozdarani H., Majidzadeh-A K (2012) Efficacy of Primed In Situ labeling (PRINS) in determination of HER-2 gene amplification and CEN-17 status in FFPE breast cancer tissues. Asian Pacific Journal of Cancer Prevention (APJCP), 13 No 1/2.

• Salimi M, Mozdarani H., Majidzadeh-A K (2012)  Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients. Med Oncol. 29(3):1502-9.

• Salimi M., Mozdarani H. (2008)  Reduction of transgenerational radiation induced genetic damages observed as numerical chromosomal abnormalities in preimplantation embryos by vitamin E. Nukleonika, 53 (4) 137-143.

• Mozdarani H., Salimi M., Froughizadeh M. (2008) Effect of cimetidine and famotidine on survival of lethally gamma irradiated mice. Iran J Radiat Res., 5 (4): 187-194.

• Mozdarani H., Salimi M. (2006) Numerical chromosome abnormalities in 8- cell embryos generated from gamma irradiated male mice in the absence and presence of vitamin E. Int J Radiat Biol., 82 (11) 817-822.

• Salimi M., Mozdarani H. (2006) Effect of vitamin E on preovulatory stage irradiated female mouse expressed as chromosomal abnormalities in generated embryos. Iran J Radiat Res., 4 (1): 54-40.

Conference papers:

• -Marzieh Beikzadeh ¹ ℗, Mahdieh Salimi ¹ ©, Exploring the Role of CircRNA BRIP1 (hsa_circ_0006968) as a Potential Biomarker in Breast Cancer: A Comparative Study on Tumor Tissues and Blood Samples.  6th international and 18th Iranian Genetic Congress, 2-4 khordad 1403. Tehran, Iran
• - Z. Aboutorab. M. Salimi, N. Allahyari, M.Ataie, Examining the expression of hsa-circ-002178 and hsa-circ-0011324 in tumor tissue of breast cancer patients compared to normal tissue. 6th international and 18th Iranian Genetic Congress, 2-4 khordad 1403. Tehran, Iran
• K.Arsin. M. Salimi, N. Allahyari, M.Ataie,Investigation of the expression of hsa_circ_0011946 in tumor tissue of breast cancer patients and its tracking in blood to find a potential biomarker associated with the disease. 6th international and 18th Iranian Genetic Congress, 2-4 khordad 1403. Tehran, Iran
• Farzam R., Salimi M., Ghoraiean P., Increased expression of CircNFIX in blood is a possible prognostic candidate for invasion in breast cancer, 5th international and 17th Iranian genetic Congress, Tehran IRAN,  15-17 Esfand 1401.
• Sana Hedayat Li., Salimi M., Ghoraiean P., Investigating the expression of a circular RNA called CircCCDC66 in the tissue of breast cancer patients in order to propose a biomarker related to breast cancer management. 5th international and 17th Iranian genetic Congress, Tehran IRAN, 15-17 Esfand 1401.
• Yeganeh Broumand Alipour, Salimi M., Ghoraiean P., Increased expression of circHIPK3 in the blood of breast cancer patients, 5th international and 17th Iranian genetic Congress, Tehran IRAN, 15-17 Esfand 1401.
• Yeganeh Broumand1*, Mahdieh Salimi2, Pegah Ghoraeian1, Mitra Ataee2, Increased expression of circHIPK3 in the blood of breast cancer patients before and after chemotherapy, Tehran IRAN, 1st International Congress Of Cancer Genomics, May 3-5, 2023.
• Sana Hedayat li, Mahdieh Salimi2, Pegah Ghoraeian1, Mitra Ataee2, Investigating the expression of a circular RNA called CircCCDC66 in theBlood of breast cancer patients in order to propose a biomarker related to breast cancer management., Tehran IRAN, 1st International Congress of Cancer Genomics, May 3-5, 2023.
• Reza Farzam, Mahdieh Salimi, Pegah Ghoraeian1, Mitra Ataee2, Circ - Dnmt1: A potential prognostic indicator for invasion in breast cancer, Tehran IRAN, 1st International Congress of Cancer Genomics, May 3-5, 2023.
• Samira Behrouzi, Salimi M., Najaf Allahyari Fard., Identication of regulatory miRNA affecting triple-negative breast cancer using bioinformatics analysis strategies, 5th international and 17th Iranian genetic Congress, Tehran IRAN, 15-17 Esfand 1401.
• Dashti Gouhari SH, Salimi M, Study of association between circular RNA000284, miR-506 and SNAIL-2 expression in breast cancer, 21th National and 9th International Congress of Biology Semnan University, Semnan, Iran, Feb 16-19, 2021
• Beikzadeh M,  Salimi M, Comparison expression of  circAmotl1/has circ 0004214 in tissue and blood samples of breast cancer and normal samples , 4^th international and 16^th Iranian Genetic Congress, GC 2020 Iran/Italy sep 30-oct 2.
• Ehsani D,  Salimi M, has_circ_0008717/circABCB10  expression analysis of  in peripheral blood  of breast cancer patients pre and post chemotherapy inorder to find potential biomarker related to response to  treatment. , 4^th international and 16^th Iranian Genetic Congress, GC 2020 Iran/Italy sep 30-oct 2.

• Bayandorno Sh., Salimi M, Vaziri HR, Mozdarani H, Circular RNA has_circ_0003227 may serve as a diagnostic marker for breast cancer , 4^th international and 16^th Irannian Genetic Congress, GC 2020 Iran/Italy sep 30-oct 2.
• Sharifi E., Salimi M., Ghoraeian P., Study of miR-4 expression and its association with tumor histopathological charachteristics to find the possible breast cancer biomarker, 2^nd International Congress on Biomedicine, 9-11 Jan 2019, Tehran, Iran
• Majidi F,  Salimi M , Mozdarani H^, miR-217 as a biomarker candidate in Iranian breast cancer patients, 2^nd International Congress on Biomedicine, 9-11 Jan 2019, Tehran, Iran
• Heidarizadi A, Salimi M., Mozdarani H., Promoter hyper-methylation and down regulation of ELF5 in Iranian patients with sporadic breast cancer., 11^th International Congress of laboratory and Clinics, 16-18 Jan 2019, Tehran, Iran
• Seyedi Moghadam A., Salimi M., Mozdarani H., Ranji N., Azimi nejadan P., Dysregulation of miR-21 as a possible prognostic marker in aggressive breast cancer, 2^nd International Congress on Biomedicine, 9-11 Jan 2019, Tehran, Iran
• Pakniyat F., Nedaie HA., Mozdarani H., Mahmoodzadeh A., Gholami S., Salimi M.,Radiobiological approach of hypo-fraction technique of grid radiation therapy in bystander cells, The third International Clinical Oncology Congress.,the 13 th Iranian annual clinical oncology congress., 19-21 dec 2018. Tehran, Iran.

• Pakniyat F., Nedaie HA., Mozdarani H., Mahmoodzadeh A., Gholami S., Salimi M., Radiation-induced bystander effect following hypo-fraction technique of grid therapy by use of sensitive molecular markers., Article 186, volume 15, special Issue-12^th . Iranian Congress of Medical Physics, November and December 2018, page 186-186.DOI: 10.22038/ijmp.2018.12801.

• Pakniyat.F. Nedaie .H.A, Mozdarani. H, Salimi. M, Mahmoodzadeh. A ,Gholami. S, Gene Expression Evaluation of in vitro Bystander cells in Spatially fractionated technique of Grid radiation therapy, 16-18 jan 2019, Tehran, Iran.

• Majidi F,  Salimi M , Mozdarani H^, Association of miR-217 upregulation and breast cancer in Iranian breast cancer patients, 3^rd Interenational and 15 Iranian Genetics congress, 13-15 may 2018.
• Seyedi Moghadam A., Salimi M., Mozdarani H., Up-regulation of cell free plasma miR-106b as a possible prognostic marker in breast cancer, 3^rd Interenational and 15 Iranian Genetics congress, 13-15 may 2018.

• Heidarizadi A, Salimi M., Mozdarani H., DOC4/IRS5 expression is altered in triple negative breat cancers, International Tehran Breast Cancer Congress, 18-20 oct 2017.

• Rahvar F. Sheikhhosseini M.  Salimi M, Study of GBP2 and AKAP4 promoter methylation pattern in tumors of breast cancer patients, 13^th  international breast cancer congress, 14-16 Feb. 2018.

• Zahed G, Salimi M,SFRP1 gene expression analysis in tumor and normal breast tissue of breat cancer patients. International Tehran Breast Cancer Congress, 18-20 oct 2017.

• Sheikhhosseini M, Salimi M, AKAP4 Gene Expression as a Candidate Breast Cancer Diagnostic Marker Detectable in PeripheralBlood, International Tehran Breast Cancer Congress, 18-20 oct 2017.

• Sheikhhosseini M, Nasirpour MH,  Salimi M, AKAP4 and DACH1 expression as two candidate breast cancer diagnostic markers, 2^nd International and 10^th National Biotechnology congress of Islamic Republic of Iran, August 29-31, 2017,Karaj, Iran.

• Nasirpour MH,  Salimi M, Mozdarani M., Expression and promoter methylation analysis of DACH1 gene in tumor and normal breast tissue in breast cancer, International Tehran Breast Cancer Congress, 18-20 oct 2017.

• Rahvar F, Salimi M, Mozdarani H, Study of GBP2 Gene Expression and Its Promoter Methylation Pattern in Tumors of Breast Cancer Patients, International Tehran Breast Cancer Congress, 18-20 oct 2017.

• sedaghati burkhani S, Salimi M., Study of miR888 and E-cadherin gene expression levels in ductal carcinoma breast cancer as possible candidate cancer biomarker, 13^th  international breast cancer congress, 18-20 oct 2017.

• Zahed G, Salimi M,Epigenetic silencing of SFRP1 gene by upregulation of mir-582-3p and hyper methylation of its promoter region in breast cancer, 13^th  international breast cancer congress, 18-20 oct 2017.

• Sheikhhosseini M, Rahvar F, Salimi M, AKAP4 and GBP2 gene expression as two candidate breast cancer diagnostic markers, 13^th  international breast cancer congress, 18-20 oct 2017.

• Rahvar F, Zahed G, Salimi M, study of GBP2 and SFRP1 promoter methylation pattern in tumors of breast cancer patients, 2^nd International and 10^th National Biotechnology congress of Islamic Republic of Iran, August 29-31, 2017,Karaj, Iran.

• Nasirpour MH,  Sheikhhosseini M, Salimi M, study of promoter methylation pattern of DACH1 and AKAP4 in breast cancer tumours, 2^nd International and 10^th National Biotechnology congress of Islamic Republic of Iran, August 29-31, 2017,Karaj, Iran.
• Zahed G,  Rahvar F, Salimi M, SFRP1 and GBP2 gene expression analysis in tumour and normal breast tissue of breast cancer patients , 2^nd International and 10^th National Biotechnology congress of Islamic Republic of Iran, August 29-31, 2017,Karaj, Iran.
• Salimi M, messenger RNA expression analysis panel in urinary sediment cells in diabetic patients in order to predict the individualized risk of diabetic nephropathy inn each patient, the first international congress of Iranian personalized medicine 25-27 Feb. 2017, Imam Khomeini hospital congress center.
• Salimi M, An indirect measure of cancer susceptibility to radiation in Iranian breast cancer patients with different ethnicity, the first international congress of Iranian personalized medicine 25-27 Feb. 2017, Imam Khomeini hospital congress center.
• Salimi M, Broumand B. MCP-1 as an informative diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.second International Congress of Nephrology & Urology 1-3 Aug, 2016. Tehran

• Rastegar pouiani, Khazaie N, Yaqubi M, Mohammadi A, Salimi M. predicting crucial role of ELF5 in breast cancer by using high throughput gene expression data, 2^nd International and 14^th Iranian Genetics Congress, Tehran, Iran.21-23 May 2016. Tehran

• Bakherad M, Salimi M, Mahjoubi F, Angaji A, Majidizadeh T. Study of LRIG1 expression in colorectal cancer as a prognostic indicator candidate, the 2^nd International GI cancer congress, 14-16 october, 2015. Tehran.
• Khazaie N, Salimi M, Mahjoubi F, Majidizadeh T, LRIG1 expression level as a biomarker in breast cancer prognosis, International Tehran Breast cancer Congress, 28-30 october 2015.
• Eskandari E, Salimi M, Mahjoubi F, Majidizadeh T, Decreased expression of tumor suppressor Bif-1, a bax activator, in colorectal cancer, the 2^nd International GI cancer congress, 14-16 october, 2015. Tehran.
• Mohammadi K, Salimi M, Mahjoubi F, Angaji A, Majidizadeh T. Association study of Bif-1 gene expression with histopathological characteristics and hormone receptors in breast cancer, International Tehran Breast cancer Congress, 28-30 october 2015.
• Mozdarani S, Salimi M, Mozdarani H, Nosrati H, Mozdarani S, Evaluation of inherent radiosensitivity of lymphocytes of breast cancer patients with different cell surface estrogen receptor by G2 cell cycle chromatid aberration, International Tehran Breast cancer Congress, 28-30 october 2015.

 

• Ranjbarpour N, Salimi M, Mozdarani H, Ghoraeiain P. study of IL-1β-511 C/T polymorphism as a candidate for diabetic nephropathy susceptible biomarker, International congress of nephrology and urology ICNU, 10-12 june 2015, Tehran-Iran.

• Ranjbarpour N, Salimi M, Mozdarani H, Ghoraeiain P. association study of MCP-1 (-2518 A/G) gene polymorphisms with diabetic nephropathy in Iranian patients, International congress of nephrology and urology ICNU, 10-12 june 2015, Tehran-Iran.

• salimi M., mozdarani S., Mozdarani M, Impact of measuring DNA damage and cytogenetic alterations in monitoring cancer prone individuals, 3^rd national congress on cellular and molecular news in non-contagious diseases., 23-25 0rdibehesh 1394,
• Salimi M, genetics in breast cancer, panel and speaker Multifactorial disorders, genetic of breast cancer, The 12^th congress & workshop of rare disease, application of advanced molecular methods for diagnosis of human genetic disorders(Rare Disease) 26 Feb-2 March, 2014, Tehran-Iran

•         Salimi M, Rajab A, Broumand B  . Comparative study of Baseline chromosome damages and cytotoxicity in prediabetes, diabetes and normal population, First International and 13^th Iranian Genetic Congress,24-26 May 2014,Shahid Beheshti University International Conferences Menu.

•         Salimi M, Broumand B ,Rajab A Genetic damage in patients with different stages of diabetic nephropathy measured by Micronucleus frequency First International and 13^th Iranian Genetic Congress,24-26 May 2014,Shahid Beheshti University International Conferences Menu,.

•          Salimi M., Mozdarani H., (2013) γ-H2AX as a protein biomarker for DNA double strand breaks in breast tissues with different HER-2 gene amplification status: A possible biomarker for radio-chemotherapy responsiveness. 3rd Iranian Congress of Medical Genetics

• Salimi M., Mozdarani H., (2013) Determination of HER-2 gene amplification and CEN-17 status in breast cancer tissues: Comparison of PRINS and FISH methods

            3rd Iranian Congress of Medical Genetics

• Salimi M., Mozdarani H., Majidzadeh-A K (2011) Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissue. 2nd Iranian Congress of Medical Genetics. May 2011, Imam Hospital, Tehran.

• Salimi M., Mozdarani H. (2006) Numerical chromosome abnormalities in 8- cell embryos generated from parental gamma irradiation in the absence and presence of vitamin E. Int. Conference on Low Dose Radiation Effects on Human Health, Nov. 20-22, 2006.

•           Salimi M., Mozdarani H. (2006) Frequency of aneuploid cells in 8-cell embryos generated from gamma-irradiated male compared with preovulatory stage irradiated female mouse. 1st Human, Life and Radiation Conference, 29-31 Oct 2006, Rafsanjan, Iran.

•           Salimi M., Mozdarani H. (2006) Numerical chromosome abnormalities in 8- cell embryos generated from gamma irradiated male mice in various spermatogenesis stages. 9th Iranian Genetic Congress, May 2006, Tehran.

•           Salimi M., Mozdarani H. (2004) Numerical chromosome abnormalities in 8- cell embryos generated from gamma irradiated male mice. 11th Annual Meeting of the Middle East Fertility Society (MEFS), 1-4 Dec. 2004, Jordan.